Innovative Drug Treatment Center for Skin Diseases

The Innovative Dermatology Drug Treatment Center of Guangzhou United Family Hospital provides comprehensive, reliable, full-lifecycle dermatological medical and nursing services, including innovative medicines synchronized with the Hong Kong-Macao Drug and Medical Device Connect program, highly efficient and safe biologics, and health follow-up integrating medicines and medical devices. It provides diagnosis and treatment services for a variety of skin diseases, including but not limited to dermatitis and eczema, herpes, urticaria, allergic skin diseases, psoriasis, acne, warts, dermatophytosis, viral warts, acne, rosacea, hair loss, nail diseases, pigmented nevi, seborrheic keratosis, bromhidrosis, and sexually transmitted diseases. It can also provide various dermatological surgical services, such as excision of skin growths. We provide one-stop medical services that comply with international diagnostic and treatment standards and guidelines. We also have extensive clinical experience in skin cancer screening, childhood eczema and dermatitis, and the diagnosis and treatment of neonatal hemangiomas. We offer multiple diagnostic and treatment services, including dermoscopy, Wood's lamp examination, photodynamic therapy, electrocautery, cryotherapy, outpatient surgical excision of skin tumors, 308 nm laser treatment, and 311 nm ultraviolet treatment.

The Dermatology Department creates a caring, comfortable, and private environment for you. The dermatology medical staff all have 10–40 years of clinical experience. They diagnose and treat possible diseases of the skin, hair, and fingernails and toenails; answer questions concerning the skin, hair, or fingernails and toenails; provide information on the prevention of skin diseases and sexually transmitted diseases; and provide cosmetic treatment and care for various disfiguring skin problems.

Our Clinicians 陈红清 Director of the Dermatology & Medical Aesthetics Department; physician, Dermatology & Medical Aesthetics Department; Associate Chief Physician 陈国瑞 Specialty Director, Medical Aesthetics Department; physician, Dermatology & Medical Aesthetics Department; attending physician specializing in cosmetic dermatology 唐慧敏 Physician, Dermatology & Medical Aesthetics Department; Associate Chief Physician 黎钰莹 Physician, Dermatology & Medical Aesthetics Department; attending physician specializing in cosmetic dermatology 黄丹仪 Physician, Dermatology & Medical Aesthetics Department; attending physician specializing in cosmetic dermatology

Innovative medicines from the Hong Kong-Macao Drug and Medical Device Connect program currently available from us:

Atopic dermatitis — Dupilumab (Dupixent) Safe and reliable: The only approved treatment suitable for children aged 6 months and older and adults Precise targeting: Dual-target mechanism to prevent itching and skin lesions Significant efficacy: Skin lesions may improve by 70% after treatment; it is also effective for moderate-to-severe asthma

Psoriasis — Secukinumab (Cosentyx) / Guselkumab (Tremfya) Highly targeted: Acts on inflammatory cytokine targets without damaging other tissues Rapid onset: In patients with arthritis, swelling and pain can be relieved on the day of injection; skin rashes may respond after only 2 injections Short treatment course: Fewer injections, less discomfort, and lower time costs of treatment

Chronic urticaria — Omalizumab (Xolair®) Symptom control: The response rate exceeds 90% in patients with chronic spontaneous urticaria High safety: The only targeted biologic with an asthma indication for patients aged over 6 years Convenient treatment: Only one injection is required each month

Vitiligo — Ruxolitinib cream A selective JAK1/JAK2 inhibitor with a unique mechanism of action Eligible population: For the treatment of non-segmental vitiligo with facial involvement in adolescents and adults aged 12 years and older Significant efficacy: After 24 weeks of topical treatment, lesions show significant repigmentation; with longer treatment, patients' lesions may continue to repigment.

Alopecia areata — Ritlecitinib tosylate (Litfulo) Innovative medicine: The first and only medicine worldwide for severe alopecia areata in both adolescents aged ≥12 years and adults Proven efficacy: Significantly improves symptoms of severe alopecia areata at 24 weeks, with efficacy maintained through 48 weeks; at that time, 50% of adolescent patients achieve scalp hair coverage of 80% or more; eyebrow regrowth improves in 67% of adolescent patients with severe alopecia areata, and eyelash regrowth improves in 73% of patients Good tolerability with long-term treatment; common adverse events are mostly mild to moderate

Systemic lupus erythematosus — Anifrolumab Innovative and precise: The world's first and only lupus treatment targeting the type I interferon pathway Proven efficacy: Rapid relief can occur within one week of use; after four weeks, 2/3 of patients have a glucocorticoid dose of ≤5 mg, and 1/3 achieve steroid-free treatment High safety: Adverse reactions are mainly mild or moderate and can resolve without discontinuing treatment

Services We Currently Provide Diagnosis and treatment of diseases of the skin, hair, and nails, including: Acne Actinic keratosis Tinea pedis Atopic dermatitis Bullous skin diseases Contact dermatitis (skin allergy) Eczema Hair loss Herpes Impetigo Keloids Lower-extremity ulcers Lice infestation Lichen planus Melasma Nevi Molluscum contagiosum Onychomycosis Perioral dermatitis Pityriasis rosea Port-wine stains Post-inflammatory hyperpigmentation Pruritus Psoriasis Lupus erythematosus Seborrheic dermatitis Seborrheic keratosis Skin cancer Skin infections Skin tags Sunburn Tinea versicolor Urticaria Hemangioma Vitiligo Warts Sexually transmitted diseases Condyloma acuminatum Syphilis Gonorrhea Nongonococcal urethritis Genital herpes

Treatment Methods We Provide Common treatments include: Cryotherapy: Removal of benign or precancerous skin lesions by freezing them with liquid nitrogen Electrocautery: Burning away benign or precancerous skin lesions using high-frequency electric current Minor surgery: Surgical excision of skin lesions Skin lesion biopsy: Obtaining a small piece of skin lesion tissue for more in-depth medical analysis, such as pathological examination UVB phototherapy: Treatment of skin diseases with ultraviolet light, such as psoriasis, vitiligo, and hair loss Laser: Treatment of various proliferative skin diseases and vascular diseases Photodynamic therapy: Treatment of condyloma acuminatum, acne, rosacea, skin cancer and precancerous lesions, port-wine stains, and other conditions Facial care: Treatment of acne, melasma, seborrheic dermatitis, flat warts, and other conditions

Skin Cancer Screening and Treatment Routine screening Patient medical education: Skin protection and self-monitoring Skin cancer treatment: Surgery, topical therapy, and other treatments.